|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.12 CHF | +0.20% |
|
+5.03% | +5.01% |
| 05:22pm | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
| 04:55pm | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
E-mail: investor.relations@novartis.com Central North America Samir Shah +41 61 324 7944 Sloan Simpson +1 862 778 5052 Thomas Hungerbuehler +41 61 324 8425 Isabella Zinck +41 61 324 7188
(END) Dow Jones Newswires
December 18, 2020 16:50 ET (21:50 GMT)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.01% | 199B | |
| +25.05% | 672B | |
| +25.87% | 570B | |
| -5.49% | 360B | |
| +16.03% | 321B | |
| +8.68% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| -9.03% | 149B | |
| -4.84% | 147B |
NOVARTIS AG 
